Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (SHE:300357)

China flag China · Delayed Price · Currency is CNY
24.15
-0.41 (-1.67%)
Mar 9, 2026, 3:04 PM CST
11.19%
Market Cap 12.64B
Revenue (ttm) 1.05B
Net Income (ttm) 390.43M
Shares Out 523.58M
EPS (ttm) 0.75
PE Ratio 32.39
Forward PE 31.36
Dividend 0.22 (0.90%)
Ex-Dividend Date Jan 20, 2026
Volume 9,047,975
Average Volume 6,143,934
Open 24.23
Previous Close 24.56
Day's Range 23.89 - 24.33
52-Week Range 18.60 - 35.84
Beta 0.60
RSI 22.19
Earnings Date Apr 24, 2026

About SHE:300357

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceutical products for the diagnosis and treatment of allergic diseases in China and internationally. The company offers Changdi, a dust mine drops; Changhao, an artemisia annua pollen allergen sublingual drops; and Changdian, a dust mite skin prick diagnostic kit. It also involved in the research and development of stem cells and medical artificial intelligence solutions. The company was founded in 2002 a... [Read more]

Sector Healthcare
Founded 2002
Employees 1,679
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300357
Full Company Profile

Financial Performance

In 2024, SHE:300357's revenue was 925.39 million, an increase of 9.10% compared to the previous year's 848.19 million. Earnings were 317.82 million, an increase of 2.46%.

Financial Statements

News

There is no news available yet.